TWI374739B - Novel medicament combinations for the treatment of respiratory diseases - Google Patents

Novel medicament combinations for the treatment of respiratory diseases Download PDF

Info

Publication number
TWI374739B
TWI374739B TW101108945A TW101108945A TWI374739B TW I374739 B TWI374739 B TW I374739B TW 101108945 A TW101108945 A TW 101108945A TW 101108945 A TW101108945 A TW 101108945A TW I374739 B TWI374739 B TW I374739B
Authority
TW
Taiwan
Prior art keywords
amino
phenyl
ethyl
fluoro
hydroxy
Prior art date
Application number
TW101108945A
Other languages
English (en)
Chinese (zh)
Other versions
TW201231055A (en
Inventor
Ingo Konetzki
Thierry Bouyssou
Philipp Lustenberger
Michael P Pieper
Andreas Schnapp
Christoph Hoenke
Sabine Pestel
Klaus Rudolf
Michel Pairet
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI374739(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de
Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TW201231055A publication Critical patent/TW201231055A/zh
Application granted granted Critical
Publication of TWI374739B publication Critical patent/TWI374739B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
TW101108945A 2004-04-22 2005-04-21 Novel medicament combinations for the treatment of respiratory diseases TWI374739B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004019540A DE102004019540A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de) 2004-11-03 2004-11-03 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496 2005-02-07

Publications (2)

Publication Number Publication Date
TW201231055A TW201231055A (en) 2012-08-01
TWI374739B true TWI374739B (en) 2012-10-21

Family

ID=34966478

Family Applications (2)

Application Number Title Priority Date Filing Date
TW094112735A TWI372056B (en) 2004-04-22 2005-04-21 Novel medicament combinations for the treatment of respiratory diseases
TW101108945A TWI374739B (en) 2004-04-22 2005-04-21 Novel medicament combinations for the treatment of respiratory diseases

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW094112735A TWI372056B (en) 2004-04-22 2005-04-21 Novel medicament combinations for the treatment of respiratory diseases

Country Status (33)

Country Link
EP (2) EP1781298B1 (enExample)
JP (1) JP2007533683A (enExample)
KR (2) KR20130049840A (enExample)
AR (1) AR049262A1 (enExample)
AT (1) ATE539754T1 (enExample)
AU (1) AU2005235419B2 (enExample)
BE (1) BE2015C065I2 (enExample)
BR (1) BRPI0510080B8 (enExample)
CA (1) CA2559699C (enExample)
CY (3) CY1113890T1 (enExample)
DK (2) DK2422786T3 (enExample)
EA (1) EA013157B1 (enExample)
EC (1) ECSP066947A (enExample)
ES (2) ES2523518T3 (enExample)
FI (1) FIC20170005I1 (enExample)
FR (1) FR16C0029I2 (enExample)
HU (1) HUS1500058I1 (enExample)
IL (2) IL177685A (enExample)
LT (1) LTC1781298I2 (enExample)
LU (1) LU93066I2 (enExample)
MY (1) MY148945A (enExample)
NL (1) NL300779I2 (enExample)
NO (2) NO337714B1 (enExample)
NZ (1) NZ550797A (enExample)
PE (1) PE20060462A1 (enExample)
PL (2) PL2422786T3 (enExample)
PT (2) PT1781298E (enExample)
SG (1) SG152237A1 (enExample)
SI (2) SI2422786T1 (enExample)
TW (2) TWI372056B (enExample)
UY (1) UY28861A1 (enExample)
WO (1) WO2005102349A1 (enExample)
ZA (1) ZA200606624B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7923455B2 (en) * 2005-01-28 2011-04-12 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
EP1855689A1 (en) * 2005-02-16 2007-11-21 Boehringer Ingelheim International GmbH Pharmaceutical compositions comprising anticholinergics and etiprednol
ES2530991T3 (es) 2005-08-15 2015-03-09 Boehringer Ingelheim Int Procedimiento para la obtención de betamiméticos
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
TWI389692B (zh) * 2005-10-10 2013-03-21 Boehringer Ingelheim Int 用以吸入β-共效劑的氣溶膠調配物
CA2627982C (en) 2005-11-10 2013-09-10 Nicholas S. Bodor Soft anticholinergic esters
CA2642239A1 (en) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
ATE505193T1 (de) * 2006-08-07 2011-04-15 Boehringer Ingelheim Int Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
CA2667543A1 (en) * 2006-10-26 2008-05-02 Boehringer Ingelheim International Gmbh New pharmaceutical combinations for treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
JP5336516B2 (ja) 2008-02-07 2013-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング スピロ環式複素環化合物、該化合物を含む医薬品、その使用及びその製造方法
CA2733153C (en) 2008-08-08 2016-11-08 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
CA2744655A1 (en) * 2008-11-27 2010-06-03 Boehringer Ingelheim International Gmbh Novel powdered crystalline medicines for inhalation
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
PT83094B (pt) 1985-07-30 1993-07-30 Glaxo Group Ltd Dispositivos proprios para a administracao de medicamentos a pacientes
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
CN1426401A (zh) 2000-04-27 2003-06-25 贝林格尔英格海姆法玛公司 新的长效倍他米美类药物(betamimetics)其制备方法,及其作为药物组合物的用途
DK1326862T3 (da) 2000-10-12 2004-11-22 Boehringer Ingelheim Pharma Krystallinsk monohydrat af tiotropiumbromid, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel
CA2450961C (en) 2001-06-22 2010-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
AU2005235419B2 (en) 2010-11-04
CA2559699C (en) 2012-06-19
CY2017014I2 (el) 2017-11-14
AU2005235419A1 (en) 2005-11-03
NL300779I2 (nl) 2017-11-02
DK1781298T3 (da) 2012-05-07
HUS1500058I1 (hu) 2016-01-28
CY1113890T1 (el) 2016-07-27
KR20070015592A (ko) 2007-02-05
IL177685A0 (en) 2006-12-31
PL1781298T4 (pl) 2017-07-31
PT2422786E (pt) 2014-11-12
KR20130049840A (ko) 2013-05-14
SI2422786T1 (sl) 2014-12-31
NO20065060L (no) 2006-11-21
AR049262A1 (es) 2006-07-12
FR16C0029I1 (enExample) 2016-08-26
ATE539754T1 (de) 2012-01-15
ES2523518T3 (es) 2014-11-26
IL177685A (en) 2013-10-31
ES2380370T3 (es) 2012-05-11
SG152237A1 (en) 2009-05-29
PE20060462A1 (es) 2006-06-19
LU93066I2 (fr) 2016-07-11
NO2016022I2 (no) 2016-12-01
IL226562A0 (en) 2013-06-27
ZA200606624B (en) 2008-01-08
NO337714B1 (no) 2016-06-06
EP2422786A1 (de) 2012-02-29
EA200601846A1 (ru) 2007-04-27
EA013157B1 (ru) 2010-02-26
EP1781298B1 (de) 2012-01-04
BE2015C065I2 (enExample) 2024-08-08
PL1781298T3 (pl) 2012-06-29
WO2005102349A1 (de) 2005-11-03
EP1781298A1 (de) 2007-05-09
MY148945A (en) 2013-06-14
UY28861A1 (es) 2005-11-30
KR101287460B1 (ko) 2013-07-23
PT1781298E (pt) 2012-02-03
TWI372056B (en) 2012-09-11
NZ550797A (en) 2010-08-27
BRPI0510080B8 (pt) 2021-05-25
TW201231055A (en) 2012-08-01
PL2422786T3 (pl) 2015-02-27
ECSP066947A (es) 2007-01-26
BRPI0510080B1 (pt) 2020-08-18
JP2007533683A (ja) 2007-11-22
CA2559699A1 (en) 2005-11-03
CY2017014I1 (el) 2017-11-14
CY1115719T1 (el) 2017-01-25
FR16C0029I2 (fr) 2017-01-27
LTC1781298I2 (lt) 2018-09-25
BRPI0510080A (pt) 2007-10-16
FIC20170005I1 (fi) 2017-01-13
SI1781298T1 (sl) 2012-04-30
DK2422786T3 (da) 2014-11-17
NO2016022I1 (no) 2016-12-01
EP2422786B1 (de) 2014-08-13

Similar Documents

Publication Publication Date Title
TWI374739B (en) Novel medicament combinations for the treatment of respiratory diseases
US20050239778A1 (en) Novel medicament combinations for the treatment of respiratory diseases
KR101270447B1 (ko) 신규하고 에난티오머적으로 순수한 베타-효능제, 이의제조방법 및 약제 제형으로서의 이의 용도
DE102004019540A1 (de) Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EA008665B1 (ru) Лекарственные средства для лечения хронического обструктивного заболевания лёгких
TW200817009A (en) Pharmaceutical combinations for the treatment of respiratory diseases
JP2009511541A (ja) 呼吸器系疾患治療用の新規な医薬組成物
JP4620730B2 (ja) ベータ作動薬を含む吸入用エアロゾル製剤
JP2009500310A (ja) 長時間作用性のベータ作用薬と少なくとも１種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物
TW200803848A (en) Medicament combinations for the treatment of respiratory diseases
ES2360963T3 (es) Combinaciones de fármacos para el tratamiento de enfermedades de las vías respiratorias.
TW200804360A (en) Novel enantiomeric pure beta agonists, manufacturing and use as a medicament thereof
DE102004052987A1 (de) Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
HK1134018A (en) Drug combinations for treating airway diseases
MXPA06011721A (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
TW200940065A (en) Crystalline, enantiomerically pure salt of a beta-agonist and the use thereof as a drug
MXPA06010577A (en) Benzoxazine for treating respiratory tract diseases
HK1144938A (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent